# Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 2 of a 4-Part Series

Page: https://stenobird.com/podcast/gynecologic-oncology-update-612940/meet-the-professor-optimizing-the-management-of-ovarian-cancer-part-2-of-a-4-part-series
Text version: https://stenobird.com/podcast/gynecologic-oncology-update-612940/meet-the-professor-optimizing-the-management-of-ovarian-cancer-part-2-of-a-4-part-series.md
Podcast: [Gynecologic Oncology Update](https://stenobird.com/podcast/gynecologic-oncology-update-612940)
Published: 2023-11-02T12:04:00+00:00
Episode link: https://gynecologic-oncology.captivate.fm/episode/meet-the-professor-optimizing-the-management-of-ovarian-cancer-part-2-of-a-4-part-series
Audio file: https://dts.podtrac.com/redirect.mp3/podcasts.captivate.fm/media/534d51a9-e7f9-4980-aeb3-7eaca314c439/mtpovarian23-part2-converted.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/gynecologic-oncology-update-612940/episodes/meet-the-professor-optimizing-the-management-of-ovarian-cancer-part-2-of-a-4-part-series
Duration seconds: 3834

## Resource

Dr David M O’Malley from the Ohio State University and the James Cancer Center in Columbus, Ohio, discusses optimizing the management of ovarian cancer.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/gynecologic-oncology-update-612940/episodes/meet-the-professor-optimizing-the-management-of-ovarian-cancer-part-2-of-a-4-part-series/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/gynecologic-oncology-update-612940/meet-the-professor-optimizing-the-management-of-ovarian-cancer-part-2-of-a-4-part-series.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.